Germany Contraceptive Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Germany Contraceptive Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Germany contraceptive devices market is poised to grow at a CAGR of 4.8% during the forecasted period.

The pandemic had an adverse effect on the studied market. For instance, a research study titled "Contraception access during the COVID-19 pandemic" that was published in October 2020 stated that one of the main obstacles to access is a lack of contraceptive drugs and devices as a result of supply chain disruption. The largest condom company in the world (Malaysia's Karex Bhd), which makes one in every five condoms worldwide, was compelled to close in March, effectively restricting condom exports. Similar to how the impact is localized, over 100 clinics and/or community-based service outlets have closed in Pakistan, El Salvador, Zambia, Sudan, Colombia, Malaysia, Uganda, Ghana, Germany, Zimbabwe, and Sri Lanka, according to reports from those countries. The Government of Germany announced that, in addition to its annual core contribution of EUR 5 million, it will contribute an additional EUR 20 million to UNAIDS in 2020 to strengthen the response to HIV during the COVID-19 pandemic, according to a German Health Alliance article titled "Germany ramps up its contribution to the HIV response with an extra €20 million to UNAIDS" that was published in June 2020. Thus, the market is expected to show positive growth in future.

The major factors propelling the growth of the German contraceptive devices market include the increasing incidence of sexually transmitted diseases, an increasing rate of unintended pregnancies, and the rise in government initiatives. The variations between unwanted first pregnancies in the life history of 20-44-year-old women are examined in the research study, "Unintended conceptions leading to desirable pregnancies - an integrative view on pregnancy acceptance from a mixed-methods study in Germany," published in June 2021. Response and acceptance of pregnancy are given particular focus. This project will advance knowledge of "satisfaction with an unwanted pregnancy" by examining drivers and dynamics. Significant influences included intent to become pregnant, use of contraceptives, living arrangements, and views. According to the World Bank collection of development indicators the prevalence of HIV, the total (% of the population aged 15-49) in Germany was 0.100 as of 2020. Its highest value over the past 30 years was 0.100 in 2020, while its lowest value was 0.100 in 1990. Thus, the abovementioned factors are expected to increase market growth.

Key Market TrendsCondoms are Expected to Dominate the Contraceptive Devices Market

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis. An external condom is more effective than a conventional one, according to a DurexCondoms June 2022 article titled "Want to know about contraception advantages and cons." The effectiveness of these condoms is 82% when used as directed. Even while internal condoms typically outperform external ones in terms of efficacy, they are still 79% effective when used as directed.

Factors such increasing prevalence of sexually transmitted diseases such as syphilis is expected to increase the market growth. The estimated incidence rate for syphilis (6.5/100,000 standardized person-years) would result in an estimated 5,256 cases for the German reference population, according to a research study published in April 2022 under the title "Epidemiology, Management, Quality of Testing, and Cost of Syphilis in Germany: A Retrospective Model Analysis." Chlamydia appears to primarily affect adolescents and young adults in Germany, with a similar overall prevalence in men and women but with slightly different age distributions, according to a research study published in June 2022 under the title "Prevalence of Chlamydia trachomatis in the general population in Germany - a triangulation of data from two population-based health surveys and a laboratory sentinel system." The current screening program covers women who are most at risk for chlamydia, but given the ongoing debates in high-income nations about the cost-effectiveness and benefit-to-harm ratio of these programs, the program's goal needs to be reconsidered. Thus, the abovementioned factors are expected to increase market growth.

Competitive Landscape

The Germany contraceptive devices market is fragmented and competitive and consists of several major players. Market leaders with more funds for research and a better distribution system have established their position in the market studied. The major players consist of Allergan PLC, Bayer Healthcare, Cooper Surgical Inc., and Pfizer Inc, among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.